As one of our primary goals was to investigate the potential importance of ICRs in γδ T cell subsets in health and in cancer, we additionally assessed expression of PD-1, TIM-3, LAG-3, TIGIT and CTLA-4 by flow cytometry in all patients. The gene discussed is LAG3; the disease is cancer.